Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase

Journal of Controlled Release

Volumn 137, Issue 2, 2009, Pages 110-115

  Hyoudou, Kenji ^a   Nishikawa, Makiya ^a   Ikemura, Mai ^a   Kobayashi, Yuki ^a   Mendelsohn, Adam ^a,b   Miyazaki, Nobuhiko ^c   Tabata, Yasuhiko ^c   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Catalase; Controlled release; Gelatin hydrogel; Pegylation; Spontaneous metastasis

Indexed keywords

CATALASE; CONTROLLED RELEASE; GELATIN HYDROGEL; PEGYLATION; SPONTANEOUS METASTASIS;

CARDIOVASCULAR SYSTEM; CELL CULTURE; HYDROGELS; OXYGEN; PLASMAS; POLYETHYLENE GLYCOLS; TUMORS;

PATHOLOGY;

CATALASE; GELATIN; INDIUM 111; LUCIFERASE; MACROGOL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENCY; ENZYME ACTIVITY; HYDROGEL; INHIBITION KINETICS; LUNG METASTASIS; MALE; MELANOMA; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; SUBCUTANEOUS TISSUE TUMOR; SUSTAINED DRUG RELEASE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATALASE; DELAYED-ACTION PREPARATIONS; GELATIN; HYDROGEL; INJECTIONS, SUBCUTANEOUS; LUNG; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; POLYETHYLENE GLYCOLS;

EID: 67349205391     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.04.005     Document Type: Article

References (42)

1. Noltenius C., and Noltenius H. Dormant tumor cells in liver and brain. An autopsy study on metastasizing tumors. Pathol Res Pract. 179 4-5 (1985) 504-511
2. Naumov G.N., Townson J.L., MacDonald I.C., Wilson S.M., Bramwell V.H., Groom A.C., and Chambers A.F. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 82 3 (2003) 199-206
3. Vessella R.L., Pantel K., and Mohla S. Tumor cell dormancy: an NCI workshop report. Cancer Biol Ther. 6 9 (2007) 1496-1504
4. Sawyer T.K. Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors. Expert Opin Investig Drugs. 13 1 (2004) 1-19
5. Orr F.W., Wang H.H., Lafrenie R.M., Scherbarth S., and Nance D.M. Interactions between cancer cells and the endothelium in metastasis. J Pathol. 190 3 (2000) 310-329
6. Wu W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25 4 (2006) 695-705
7. Wu W.S., Wu J.R., and Hu C.T. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev. 27 2 (2008) 303-314
8. Ushio-Fukai M., and Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266 1 (2008) 37-52
9. Nishikawa M., Tamada A., Hyoudou K., Umeyama Y., Takahashi Y., Kobayashi Y., Kumai H., Ishida E., Staud F., Yabe Y., Takakura Y., Yamashita F., and Hashida M. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis. 21 3 (2004) 213-221
10. Nishikawa M., Hyoudou K., Kobayashi Y., Umeyama Y., Takakura Y., and Hashida M. Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release. 109 1-3 (2005) 101-107
11. Nishikawa M., Tamada A., Kumai H., Yamashita F., and Hashida M. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer. 99 3 (2002) 474-479
12. Hyoudou K., Nishikawa M., Umeyama Y., Kobayashi Y., Yamashita F., and Hashida M. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res. 10 22 (2004) 7685-7691
13. Hyoudou K., Nishikawa M., Kobayashi Y., Umeyama Y., Yamashita F., and Hashida M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med. 41 9 (2006) 1449-1458
14. Hyoudou K., Nishikawa M., Kobayashi Y., Kuramoto Y., Yamashita F., and Hashida M. Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase. Clin Exp Metastasis. 23 5-6 (2006) 269-278
15. Hyoudou K., Nishikawa M., Kobayashi Y., Mukai S., Ikemura M., Kuramoto Y., Yamashita F., and Hashida M. Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice. J Control Release. 119 1 (2007) 121-127
16. Hyoudou K., Nishikawa M., Ikemura M., Kobayashi Y., Mendelsohn A., Miyazaki N., Tabata Y., Yamashita F., and Hashida M. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells. J Control Release. 122 2 (2007) 151-158
17. Ozeki M., and Tabata Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed. 16 5 (2005) 549-561
18. Young S., Wong M., Tabata Y., and Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release. 109 1-3 (2005) 256-274
19. Yabe Y., Nishikawa M., Tamada A., Takakura Y., and Hashida M. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther. 289 2 (1999) 1176-1184
20. Tabata Y., Nagano A., Muniruzzaman M., and Ikada Y. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials. 19 19 (1998) 1781-1789
21. Poste G., Doll J., Hart I.R., and Fidler I.J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40 5 (1980) 1636-1644
22. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., and Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release. 64 1-3 (2000) 133-142
23. Yamamoto M., Takahashi Y., and Tabata Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng. 12 5 (2006) 1305-1311
24. Nakae M., Kamiya H., Naruse K., Horio N., Ito Y., Mizubayashi R., Hamada Y., Nakashima E., Akiyama N., Kobayashi Y., Watarai A., Kimura N., Horiguchi M., Tabata Y., Oiso Y., and Nakamura J. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes. 55 5 (2006) 1470-1477
25. Lyon M., Deakin J.A., Mizuno K., Nakamura T., and Gallagher J.T. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem. 269 15 (1994) 11216-11223
26. Kinosaki M., Yamaguchi K., Murakami A., Ueda M., Morinaga T., and Higashio K. Identification of heparin-binding stretches of a naturally occurring deleted variant of hepatocyte growth factor (dHGF). Biochim Biophys Acta. 1384 1 (1998) 93-102
27. Staud F., Nishikawa M., Morimoto K., Takakura Y., and Hashida M. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats. J Pharm Sci. 88 6 (1999) 577-585
28. Engers R., and Gabbert H.E. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol. 126 12 (2000) 682-692
29. Morris V.L., Koop S., MacDonald I.C., Schmidt E.E., Grattan M., Percy D., Chambers A.F., and Groom A.C. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis. 12 6 (1994) 357-367
30. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., and Groom A.C. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 153 3 (1998) 865-873
31. Cameron M.D., Schmidt E.E., Kerkvliet N., Nadkarni K.V., Morris V.L., Groom A.C., Chambers A.F., and MacDonald I.C. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 60 9 (2000) 2541-2546
32. Ikada Y., and Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev. 31 3 (1998) 287-301
33. Lu P.L., Lai J.Y., Tabata Y., and Hsiue G.H. A methodology based on the "anterior chamber of rabbit eyes" model for noninvasively determining the biocompatibility of biomaterials in an immune privileged site. J Biomed Mater Res A. 86 1 (2008) 108-116
34. Draye J.P., Delaey B., Van de Voorde A., Van Den Bulcke A., De Reu B., and Schacht E. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films. Biomaterials. 19 18 (1998) 1677-1687
35. Rathna G.V. Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability. J Mater Sci Mater Med. 19 6 (2008) 2351-2358
36. Nishikawa M., and Hashida M. Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv. 3 3 (2006) 355-369
37. Mendoza L., Carrascal T., De Luca M., Fuentes A.M., Salado C., Blanco J., and Vidal-Vanaclocha F. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver. Hepatology. 34 2 (2001) 298-310
38. Anasagasti M.J., Alvarez A., Martin J.J., Mendoza L., and Vidal-Vanaclocha F. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology. 25 4 (1997) 840-846
39. Warner H.R. Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med. 17 3 (1994) 249-258
40. Kobayashi Y., Nishikawa M., Hyoudou K., Yamashita F., and Hashida M. Hydrogen peroxide-mediated nuclear factor kappaB activation in both liver and tumor cells during initial stages of hepatic metastasis. Cancer Sci. 99 8 (2008) 1546-1552
41. Malisza K.L., McIntosh A.R., Sveinson S.E., and Hasinoff B.B. Semiquinone free radical formation by daunorubicin aglycone incorporated into the cellular membranes of intact Chinese hamster ovary cells. Free Radic Res. 24 1 (1996) 9-18
42. Lazo J.S., Sebti S.M., and Schellens J.H. Bleomycin. Cancer Chemother Biol Response Modif. 16 (1996) 39-47